Status:

UNKNOWN

Impact of IntraVascular UltraSound Guidance on the Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study): Retrospective and Prospective Follow-up Study

Lead Sponsor:

Yonsei University

Conditions:

Myocardial Ischemia(Implanted Drug-eluting Stents Because of Ischemic Heart Disease(Stable Angina, Acute Coronary Syndrome))

Eligibility:

All Genders

20-85 years

Brief Summary

The investigator aimed to evaluate the long-term (up to 10 years) follow-up of the patients who enrolled the IVUS-XPL study (Impact of IntraVascular UltraSound Guidance on the Outcomes of Xience Prime...

Detailed Description

The investigator will follow-up (up to 10 years) the patients who enrolled the IVUS-XPL study (Impact of IntraVascular UltraSound Guidance on the Outcomes of Xience Prime Stents in Long Lesions).

Eligibility Criteria

Inclusion

  • 1\. The patients who enrolled in the XPL-IVUS study.
  • 2\. Provision of informed consent

Exclusion

  • 1\. This observational study does not have any specific exclusion criteria.

Key Trial Info

Start Date :

March 15 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 31 2025

Estimated Enrollment :

1400 Patients enrolled

Trial Details

Trial ID

NCT03866486

Start Date

March 15 2019

End Date

January 31 2025

Last Update

October 14 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine

Seoul, South Korea, 120-752